FGFBP2 and hepatocellular carcinoma: Notably, FGFBP2+ T cells, B3GNT7+ T cells, LAG3+ T cells, HPGDS+ T cells, and RCAN3+ T cells activities were not significantly associated with the prognosis of HCC patients (Supplementary Figure 3).